Blog

Post-COVID syndrome is increasingly affecting the general population as many people are now falling ill, although, fortunately, without the need for hospitalization or admission to the ICU.

Post-Covid syndrome is defined as the set of symptoms (physical and mental) that begin with the illness and last for at least 3 months in total, strongly affect the patient’s quality of life and are not explained by a different diagnosis. Fatigue, shortness of breath, cough, headache, impaired sense of smell, memory, and concentration are the main symptoms. We will briefly discuss the post-COVID syndrome of the infection that was treated at home, therefore the mild form.

The reason for this short article was a recently published Italian study (July 2022) that correlates vaccination status with the likelihood of someone developing post-COVID syndrome after becoming ill. It states that the greater the number of vaccinations, the lower the likelihood of post-COVID syndrome (42% in the unvaccinated vs 16% in the 3 doses).

Many are hesitant to proceed with the 4th dose of the vaccine, most of them are waiting for the updated vaccine in the Fall.

Because the COVID vaccine is a unique pharmaceutical product, it is administered free of charge and under central planning, has a specific time frame for availability, is not subject to payment and purchase, is available based on criteria, is not stored (as is the case with a medicine that we purchase from the pharmacy) and is not exchanged, it would be wise for everyone to consider accepting it now that it is available.

In conclusion, the prevention of post-COVID syndrome is directly related to the prevention of acute infection through regular vaccination, mask use, social distancing and hand hygiene.

The question that remains to be answered is whether the appropriate administration of antibiotics (especially those with anti-inflammatory and antiviral activity) can prevent the progression of acute infection to post-COVID syndrome. Time will refute or support this position.